-: The Trial For #ClinicalEquality, Aniyah

Why do clinical oncology trials discriminate against people of color when cancer kills indiscriminately? In honor of World Cancer Day, FCB Health Network is proud to announce “The Trial for #ClinicalEquality,” an initiative dedicated to achieving racial equity in clinical trials. Clinical equality is a fundamental first step to dismantling systemic racism, as there is no more inalienable right than the right to have an equal chance in the battle for life. African Americans have the highest death rate and shortest survival rate of any racial and ethnic group, according to the National Cancer Society, yet African Americans are woefully underrepresented in clinical trials. African Americans comprise 13 percent of the U.S. population, yet only three percent participate in oncology trials. Likewise, Hispanics comprise 19 percent of the U.S. population, yet only six percent participate in clinical trials. 1,2 These trials are essential to discovering new ways to detect, diagnose and treat diseases, as well as reducing the incidence of disease.